Can a nine-month regimen be used to treat isoniazid resistant tuberculosis diagnosed after standard treatment is started?

Journal of Infection

Volumn 42, Issue 1, 2001, Pages 1-3

  Ormerod, L P ^a,b   Horsfield, N ^a   Green, R M ^a  

^a ROYAL BLACKBURN HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; CAPREOMYCIN; ETHAMBUTOL; ISONIAZID; PROTIONAMIDE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; MALE; RELAPSE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 0034930067     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2000.0773     Document Type: Article

References (7)

1. Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant organisms
2. Influence of initial drug resistance to short-course chemotherapy in pulmonary tuberculosis
3. Chemotherapy and management of tuberculosis in the United Kingdom: Recommendations 1998
4. Epidemiology of an outbreak of drug-resistant tuberculosis in the UK using restriction fragment length polymorphism
5. Chemotherapy of tuberculosis
6. Clinical guidelines: Criteria for appraisal for national use